340bemployed.org

Your Free Source for 340B News and Commentary

  • Home
  • About Us
  • Employers
  • Job Seekers
  • Advertise
  • 340B Health

WSJ Scrutinizes Florida Oncology Practice


 

Print Article

The Community Oncology Alliance has been slinging mud at 340B hospitals for months. Now, a Wall Street Journal investigation has found that a Florida oncology practice with close ties to COA racks up big dollars billing Medicare for the anemia drug Procrit, which “can speed tumor growth and hasten death in cancer patients.”

In fact, one-sixth of the $128 million that Medicare paid in 2012 for Procrit went to Fort Myers-based Florida Cancer Specialists, WSJ reports. You might recall FCS from the recent AIR 340B “summit.”  Michael Diaz, M.D., a member of the practice, sits on both the FCS and COA executive boards. Dr. Diaz spoke at the summit about “travesties” by 340B hospitals and how they cause private cancer physicians to suffer. It turns out that 28 of FCS’s doctors “were among the top 100 U.S. oncologists by 2012 Medicare payments for all services,” WSJ’s investigation found. In fact, the newspaper says 22 were paid over $3 million each by the government!

While it appears nothing was illegal about FCS doctors’ prescribing decisions, the WSJ investigation shows how private cancer clinics buy and bill certain medications to their advantage. For example, WSJ’s analysis of Medicare billing records found that FCS doctors prescribed Procrit at higher-than-average rates and billed Medicare for a whopping $20 million worth of the drug in 2012, despite FDA warnings to doctors as far back as 2002 to stop prescribing the drug liberally. Procrit is marketed by AIR 340B member Janssen, a subsidiary of Johnson & Johnson.

Private oncologists make much of their money administering high-priced drugs to patients. Because they make more money prescribing expensive meds, the WSJ piece calls into question whether medical need – or good old capitalism – is driving some private cancer doctors’ decisions. Funny, but this is the same argument COA has leveled at safety-net hospitals.

We will leave the hypocrisy aside and expect there are good medical reasons why Florida Cancer Specialists prescribes meds the way it does. After all, safety-net hospitals are in the same business of helping sick people get better. Our patients just happen to be a lot less able to pay for their care.

Follow us on X

340B Health Follow

340B Health is the leading advocate & resource for hospitals that serve their communities by participating in the 340B drug pricing program. #Protect340B

340BHealth
340bhealth 340B Health @340bhealth ·
20h

Did you know?

The 340B program has enabled covered entities to purchase discounted outpatient drugs, freeing up crucial resources to expand care where it’s needed most. When federal or state policies interfere with that, it harms patient access. #Becauseof340B

Reply on Twitter 2002465285412917532 Retweet on Twitter 2002465285412917532 Like on Twitter 2002465285412917532 Twitter 2002465285412917532
340bhealth 340B Health @340bhealth ·
19 Dec

🚨 Drugmakers continue pushing policies that sideline 340B savings, including rebate model proposals that would shift value away from safety-net hospitals. We must protect patients and the safety net. #Protect340B

Reply on Twitter 2002106692608180288 Retweet on Twitter 2002106692608180288 Like on Twitter 2002106692608180288 1 Twitter 2002106692608180288
340bhealth 340B Health @340bhealth ·
18 Dec

When local clinics use 340B savings to fund services such as medication discounts, expanded mental health care, or free vaccination clinics, it becomes about more than savings. It becomes about expanded access.

Reply on Twitter 2001766945985577331 Retweet on Twitter 2001766945985577331 Like on Twitter 2001766945985577331 Twitter 2001766945985577331
Load More

RSS 340B Informed

  • An In-Depth Look at Total 340B Purchases
  • Ideas for 340B Changes Could Lead to Legislation
  • Help From 340B After a Rare Diagnosis and an Unaffordable Bill

Copyright © 2025 · 340B Health